Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines Jul 10, 2023 | Uncategorized
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy Jun 29, 2023 | Articles, Colorectal Cancer
High-throughput identification of neoepitopes for the development of patient-specific cancer immunotherapies Jun 29, 2023 | Articles
QUILT-88: NANT Pancreatic Cancer Vaccine in 3rd, 4th, & 5th Line Advanced Disease Mar 25, 2022 | Pancreatic Cancer
NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly-Informed Integrated Immunotherapy Combining Innate High-Affinity Natural Killer (haNK) Cell Therapy with Adenoviral & Yeast-based Vaccines and Immune Checkpoint Inhibitor to Induce T-Cell Responses in Subjects with TNBC Who Have Progressed on or after Standard-of-Care Therapy Dec 11, 2019 | Triple Negative Breast Cancer
